Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,579 | -30,439 | -17,724 | -18,703 | -39,411 |
| Depreciation Amortization | N/A | 47 | 28 | 43 | 102 |
| Accounts payable and accrued liabilities | 2,242 | 1,384 | 838 | -130 | -296 |
| Other Working Capital | -100 | 3,615 | 1,992 | -1,027 | -3,104 |
| Other Operating Activity | -2,980 | 1,933 | -5,912 | -218 | 13,950 |
| Operating Cash Flow | $-7,417 | $-23,460 | $-20,778 | $-20,035 | $-28,759 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -15,124 | 2,241 | 16,215 | -31,215 |
| PPE Investments | N/A | -2 | -90 | -4 | -5 |
| Investing Cash Flow | $N/A | $-15,126 | $2,151 | $16,211 | $-31,220 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -2 |
| Common Stock Issued | 1 | 45,648 | 13,692 | N/A | 63,949 |
| Other Financing Activity | 17,873 | -156 | -211 | 0 | -617 |
| Financing Cash Flow | $17,874 | $45,492 | $13,481 | $0 | $63,330 |
| Beginning Cash Position | 10,188 | 8,910 | 14,056 | 17,880 | 14,529 |
| End Cash Position | 20,645 | 15,816 | 8,910 | 14,056 | 17,880 |
| Net Cash Flow | $10,457 | $6,906 | $-5,146 | $-3,824 | $3,351 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,417 | -23,460 | -20,778 | -20,035 | -28,759 |
| Capital Expenditure | N/A | -2 | -90 | -4 | -5 |
| Free Cash Flow | -7,417 | -23,462 | -20,868 | -20,039 | -28,764 |